Teva launches generic ExjadeExjade had a market value of $134 million for the year ended December 2018, according to IQVIA data. CBD who's who: 101 CBD101 CBD makes CBD oils in varieties called Alleviate, Chill, Boost, CBD, and Decarboxylated CBD Oil, which is heated at lower temperatures that result in a higher potency. Hikma launches Levophed generic Norepinephrine bitartrate injection had a market value of roughly $97 million for the 12 months ended January 2019. Perrigo names new CFO Ray Silcock is Perrigo's new executive vice president and CFO, replacing Ronald Winowiecki, who is resigning. Zydus Cadila receives FDA nod for generic Latuda Zydus Cadila's generic Latuda tablets provide a treatment for certain mental/mood disorders. Novartis to spin off Alcon Shares in Alcon are expected to be listed and traded on the SIX Swiss Exchange and the New York Stock Exchange under the ticker symbol ALC starting April 9. NACDS launches online resource to aid states, pharmacies in optimizing care The online NACDS Optimizing Care Process Guide is intended to advance pharmacy care for patients, the organization said. Biologics by McKesson to exclusively distribute Cablivi Biologics by McKesson is expanding its specialty pharmacy’s footprint beyond oncology. Jazz Pharmaceuticals gets FDA nod for Sunosi Sunosi provides a treatment for obstructive sleep apnea and narcolepsy patients with excessive daytime sleepiness. FDA approves new indication for Roche’s Tecentriq Tecentriq is the first cancer immunotherapy approved for the initial treatment of extensive-stage small-cell lung cancer First Previous 525 526 527 528 529 Next Last
